DYADIC INTERNATIONAL, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.45 USD | -2.59% |
|
+1.39% | -9.94% |
| 03-28 | Transcript : Dyadic International, Inc., 2023 Earnings Call, Mar 28, 2024 | |
| 03-28 | Dyadic International, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Presentation Operator MessageOperator (Operator)Good day, and welcome to the Dyadic Internatio...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Dyadic International, Inc. is a biotechnology company focused on the large-scale manufacture of proteins for use in human and animal vaccines and therapeutics and for use in non-pharmaceutical applications including food, nutrition, and wellness. The Company's gene expression and protein production platforms are based on the highly productive and scalable fungus Thermothelomyces heterothallica (formerly Myceliophthora thermophila). Its lead technology, C1-cell protein production platform, is based on an industrially proven microorganism (named C1), which is used to speed development and improve performance of biologic vaccines and drugs at flexible commercial scales for the human and animal health markets. The Company has also developed the Dapibus filamentous fungal based microbial protein production platform to enable the rapid development and large-scale manufacture of low-cost proteins, metabolites, and other biologic products for use in non-pharmaceutical applications.
Calendar
2024-05-12
- PEGS Boston Conference
Trading Rating
Investor Rating
ESG Refinitiv
C
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
1.45
USD
Average target price
7.5
USD
Spread / Average Target
+417.28%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -9.94% | 42.39M | |
| +17.96% | 44.96B | |
| +1.17% | 42.65B | |
| +48.77% | 41.85B | |
| -4.27% | 29.04B | |
| +11.42% | 26.08B | |
| -21.39% | 19.03B | |
| +4.86% | 12.75B | |
| +27.29% | 12.06B | |
| -3.50% | 11.75B |
- Stock Market
- Equities
- DYAI Stock
- News Dyadic International, Inc.
- Transcript : Dyadic International, Inc. - Shareholder/Analyst Call